Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

OraSure Technologies to Participate at Needham's Twelfth Annual Healthcare Conference



OraSure Technologies to Participate at Needham's Twelfth Annual Healthcare
Conference

BETHLEHEM, Pa., April 29, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that Douglas A. Michels, President and Chief
Executive Officer, will speak to the investment community at Needham's Twelfth
Annual Healthcare Conference in New York City at approximately 3:40 pm Eastern
Time (12:40 pm Pacific Time) on Wednesday, May 1, 2013. The conference will be
simultaneously webcast over the Internet.

Interested investors can access the live audio webcast of the discussion by
going to OraSure Technologies' web site, www.orasure.com, and clicking on the
Investor Information link. A replay of the webcast will be available on
OraSure Technologies' web site for seven days. Alternatively, you can access
the live webcast of the presentation via the following link
http://wsw.com/webcast/needham58/osur/.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. In July 2012, the Company received approval from the U.S. Food and
Drug Administration for the Company's OraQuick^® In-Home HIV Test for sale
directly to consumers in the over-the-counter (OTC) market – making it the
first and only rapid OTC HIV test approved in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection, stabilization
and preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
health. 

For more information on OraSure Technologies, please visit www.orasure.com.

CONTACT: Ronald H. Spair
         Chief Financial Officer
         610-882-1820
         Investorinfo@orasure.com
         www.orasure.com

company logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement